NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV
Product details
Registration number: SIN17148P
Classification: Prescription Only
Active ingredients: SARS-CoV-2 recombinant spike protein (Omicron JN.1)
Strength: 5 mcg/dose
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
ATC code: J07BN04
HSA approval date: 16 December 2024
Manufacturer(s): Siegfried Hameln GmbH
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17148P
Classification: Prescription Only
What active ingredients and strength are recorded for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?
According to the HSA dataset updated 7 August 2026:
Active ingredients: SARS-CoV-2 recombinant spike protein (Omicron JN.1)
Strength: 5 mcg/dose
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?
According to the HSA dataset updated 7 August 2026:
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Siegfried Hameln GmbH
Manufacturing country/countries: GERMANY
Where can I look up NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17148P or the exact product name NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV. The general register link does not preselect this product.
What are the source dates for this NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 mcg/dose (RECOMBINANT, ADJUVANTED) IN SDV record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17148P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)